Effect of chemotherapy on carcinoma in situ of the testis

Annals of Oncology

Volumn 9, Issue 6, 1998, Pages 657-660

  Christensen, T B ^a,b   Daugaard, G ^b   Geertsen, P F ^c   Von Der Maase, H ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Carcinoma in situ; Chemotherapy; Testicular cancer

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE; VINBLASTINE;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CARCINOMA IN SITU; CLINICAL ARTICLE; DRUG EFFECT; GERM CELL; HUMAN; MALE; MALE FERTILITY; NON SEMINOMATOUS GERMINOMA; ORCHIECTOMY; PRIORITY JOURNAL; SPERMATOGENESIS; TESTIS BIOPSY; TESTIS CARCINOMA;

EID: 0031852905     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008213515649     Document Type: Article

References (27)

1. Skakkebaek NE. Possible carcinoma in situ of the testis. Lancet 1972; 2: 516 7.
2. von der Maase H. Rorth M. Walbom-Jorgensen S et al. Carcinoma in situ of contralateral testis in patients with testicular germ-cell cancer: Study of 27 cases in 500 patients. BMJ 1986; 293: 1398 401 (Clin Res Ed).
3. Von der Maase H, Giwercman A, Muller J, Skakkebaek NE. Management of carcinoma in situ of the testis. Intern J Androl 1987; 10: 209 20.
4. Loy V, Dieckmann KP. Prevalence of contralateral testicular intraepithelial neoplasia (carcinoma in situ) in patients with testicular germ-cell tumour. Results of the German multicentre study. Eur Urol 1993; 23: 120 2.
5. Mumperow E, Lauke H, Holstein AF, Hartmann M. Further practical experiences in the recognition and management of carcinoma in situ of the testis. Urol Intern 1992; 48: 162-6.
6. Daugaard G, Rorth M, von der Maase H, Skakkebaek NE. Management of extragonadal germ-cell tumors and the significance of bilateral testicular biopsies. Ann Oncol 1992; 3: 283-9.
7. Daugaard G, von der Maase H, Olsen J et al. Carcinoma in situ testis in patients with assumed extragonadal germ-cell tumours. Lancet 1987; 2: 528-30.
8. Von der Maase H, Giwercman A, Skakkebaek NE. Radiation treatment of carcinoma in situ of testis. Lancet 1986; 1: 624-5 (Letter).
9. Giwereman A, von der Maase H, Berthelsen JG et al. Localized irradiation of testes with carcinoma in situ: Effects on Leydig cell function and eradication of malignant germ cells in 20 patients. J Clin Endocrinol Metab 1991; 73: 596 603.
10. Von der Maase H, Berthelsen JG, Jacobsen GK et al. Carcinoma in situ of testis eradicated by chemotherapy. Lancet 1985; 1: 98 (Letter).
11. Von der Maase H, Meinecke B, Skakkebaek NE. Residual carcinoma in situ of contralateral testis after chemotherapy. Lancet 1988; 1: 477-8 (Letter).
12. Dieckmann KP. Residual carcinoma in situ of contralateral testis after chemotherapy. Lancet 1988; 1: 765 (Letter).
13. Giwercman A, von der Maase H, Skakkebaek NE. Epidemiological and clinical aspects of carcinoma in situ of the testis. Eur Urol 1993; 23: 104-10, discussion 111-4 (Review).
14. Bottomley D, Fisher C, Hendry WF, Horwich A. Persistent carcinoma in situ of the testis after chemotherapy for advanced testicular germ-cell tumours. Br. J Urol 1990; 66: 420-4.
15. Dieckmann KP, LV. Intratesticular effects of cisplatin-based chemotherapy. Eur Urol 1995; 28: 25 30.
16. Simmonds PD, MG, Lee AH, Theaker JM et al. Orchiectomy after chemotherapy in patients with metastatic testicular cancer. Is it indicated? Cancer 1995; 75: 1018 24.
17. Setchell BP. The functional significance of the blood-testis barrier. J Androl 1980; 1: 3-11.
18. Greist A, EL, Williams SD, Donohue JP, Rowland RG. Pathologic findings at orchiectomy following chemotherapy for disseminated testicular cancer. J Clin Oncol 1984; 2: 1025 7.
19. Bohle A, SU, Sonntag RW, Scheidegger JR. Primary or secondary extragonadal germ-cell tumors? J Urol 1986; 135: 939-43.
20. Chong C, LC, von Eschenbach A, Avala A, Samuels M. Orchiectomy in advanced germ-cell cancer following intensive chemotherapy: A comparison of systemic to testicular response. J Urol 1986; 136: 1221 3.
21. Bruun E, Frimodt-Moller C, Giwercman A et al. Testicular biopsy as an outpatient procedure in screening for carcinoma in situ: Complications and the patient's acceptance. Intern J Androl 1987; 10: 199 202.
22. Williams HJ, BP, Slater NG. Testicular relapse in acute leukaemia (Letter). Lancet 1978; 2: 1152.
23. Rosenkrantz JG, WK, Ballard ET, Cox JA, Martin LW. Leukemic infiltration of the testis during long-term remission. J Pediatr Surg 1978; 13: 753-6.
24. Forrest JB, SH, Howards SS. Testicular relapse in acute childhood leukemia. J Surg Oncol 1982; 21: 132-4.
25. Ritzen EM. Testicular relapse of acute lymphoblastic leukemia (ALL). J Reprod Immunol 1990; 18: 117 21.
26. James PP, MG. Sanctuary site relapse in chemotherapy-treated testicular cancer. Ann Oncol 1992; 3: 41 3.
27. Giwercman A, vdMH, Rorth M, Skakkebaek NE. Semen quality in testicular tumour and CIS in the contralateral testis. Lancet 1993; 341: 384-5 (Letter).